Search Results - "Hollville, É"

Structural Basis of the Preferential Binding for Globo-Series Glycosphingolipids Displayed by Pseudomonas aeruginosa Lectin I by Blanchard, Bertrand, Nurisso, Alessandra, Hollville, Emilie, Tétaud, Cécile, Wiels, Joelle, Pokorná, Martina, Wimmerová, Michaela, Varrot, Annabelle, Imberty, Anne

“…The opportunistic pathogen Pseudomonas aeruginosa contains several carbohydrate-binding proteins, among which is the P. aeruginosa lectin I (PA-IL), which…”
Get full text

Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells by Renouf, B, Hollville, É, Pujals, A, Tétaud, C, Garibal, J, Wiels, J

“…p53 inactivation is often observed in Burkitt's lymphoma (BL) cells, because of either mutations in p53 gene or an overexpression of the p53-negative regulator…”
Get full text

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis by Pujals, A, Renouf, B, Robert, A, Chelouah, S, Hollville, É, Wiels, J

“…P53 inactivation is often observed in Burkitt's lymphoma (BL) cells due to mutations in the p53 gene or overexpression of its negative regulator, murine double…”
Get full text

Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy by Robert, C., Chaput, N., Lassau, N., Auperin, A., Koscielny, S., Hollville, E., Lazar, V., Lacroix, L., Soria, J., Mateus, C.

“…Abstract only…”
Get full text

Activation of the MAP-kinase pathway in the skin of patients treated with sorafenib: Clinical and molecular characterization of skin tumors associated with the multikinase inhibitor sorafenib by Mateus, C., Arnault, J., Tomasic, G., Hollville, E., Lacroix, L., Wechsler, J., Escudier, B. J., Eychene, A., Soria, J., Robert, C.

“…Abstract only…”
Get full text